Proteomics exploration reveals that actin is a signaling target of the kinase Akt

Molecular and Cellular Proteomics

Volumn 6, Issue 1, 2007, Pages 114-124

  Vandermoere, Franck ^a   El Yazidi Belkoura, Ikram ^a   Demon, Yohann ^a   Slomianny, Christian ^a   Antol, Johann ^a   Lemoine, Jérôme ^b,c   Hondermarck, Hubert ^a  

^a INSERM   (France)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTININ; BETA TUBULIN; CYCLINE; CYTOKERATIN 8; HEAT SHOCK PROTEIN 27; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN KINASE B; SMALL INTERFERING RNA; VALOSIN CONTAINING PROTEIN; WORTMANNIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL STRAIN MCF 7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; SIGNAL TRANSDUCTION;

ACTINS; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL MOVEMENT; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 33846514800     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600335-MCP200     Document Type: Article

References (52)

1. Hanada, M., Feng, J., and Hemmings, B. A. (2004) Structure, regulation and function of PKB/AKT - a major therapeutic target. Biochim. Biophys. Acta 1697, 3-16
2. Luo, J., Manning, B. D., and Cantley, L. C. (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262
3. Stal, O., Perez-Tenorio, G., Akerberg, L., Olsson, B., Nordenskjold, B., Skoog, L., and Rutqvist, L. E. (2003) Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res. 6, R37-R44
4. Knuefermann, C., Lu, Y., Liu, B., Jin, W., Liang, K., Wu, L., Schmidt, M., Mills, G. B., Mendelsohn, J., and Fan, Z. (2003) HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 22, 3205-3212
5. Downward, J. (2004) PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15, 177-182
6. Hu, L., Hofmann, J., Lu, Y., Mills, G. B., and Jaffe, R. B. (2002) Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 62, 1087-1092
7. Kozikowski, A. P., Sun, H., Brognard, J., and Dennis, P. A. (2003) Novel PI analogues selectively block activation of the pro-survival serine/ threonine kinase Akt. J. Am. Chem. Soc. 125, 1144-1145
8. Vercoutter-Edouart, A. S., Lemoine, J., Le Bourhis, X., Louis, H., Boilly, B., Nurcombe, V., Revillion, F., Peyrat, J. P., and Hondermarck, H. (2001) Proteomic analysis reveals that 14-3-3δ is down-regulated in human breast cancer cells. Cancer Res. 61, 76-80
9. Vandermoere, F., El Yazidi-Belkoura, I., Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2005) The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-κB activation induced via interaction between Akt and IκB kinase-β in breast cancer cells. Oncogene 24, 5482-5491
10. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A., and Cohen, P. (1996) Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399, 333-338
11. Obata, T., Yaffe, M. B., Leparc, G. G., Piro, E. T., Maegawa, H., Kashiwagi, A., Kikkawa, R., and Cantley, L. C. (2000) Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275, 36108-36115
12. Villafuerte, B. C., Phillips, L. S., Rane, M. J., and Zhao, W. (2004) Insulin-response element-binding protein 1: a novel Akt substrate involved in transcriptional action of insulin. J. Biol. Chem. 279, 36650-36659
13. Du, K., and Montminy, M. (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377-32379
14. Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K., and Tavare, J. M. (2002) The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J. Biol. Chem. 277, 33895-33900
15. Ma, A. D., Metjian, A., Bagrodia, S., Taylor, S., and Abrams, C. S. (1998) Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase γ, a Rac guanosine exchange factor, and Rac. Mol. Cell Biol. 18, 4744-4751
16. Hill, K., Welti, S., Yu, J., Murray, J. T., Yip, S. C., Condeelis, J. S., Segall, J. E., and Backer, J. M. (2000) Specific requirement for the p85-p100α phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J. Biol. Chem. 275, 3741-3744
17. Kang, K. W., Lee, S. J., Park, J. W., and Kim, S. G. (2002) Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 62, 1001 -1010
18. Hondermarck, H. (2003) Breast cancer: when proteomics challenges biological complexity. Mol. Cell. Proteomics 2, 281-291
19. Hondermarck, H. (ed) (2004) Biomedical and Pharmaceutical Applications of Proteomics, Kluwer-Springer, Dordrecht, The Netherlands
20. Kabuyama, Y., Resing, K. A., and Ahn, N. G. (2004) Applying proteomics to signaling networks. Curr. Opin. Genet. Dev. 14, 492-498
21. Vandermoere, F., El Yazidi-Belkoura, I., Slomianny, C., Demont, Y., Bidaux, G., Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J. Biol. Chem. 281, 14307-14313
22. Mackintosh, C. (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381, 329-342
23. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., and Sukumar, S. (2000) High frequency of hypermethylation at the 14-3-3 δ locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 97, 6049-6054
24. Liu, M. Y., Cai, S., Espejo, A., Bedford, M. T., and Walker, C. L. (2002) 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Cancer Res. 62, 6475-6480
25. Maga, G., and Hubscher, U. (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060
26. Maga, G., Blanca, G., Shevelev, I., Frouin, I., Ramadan, K., Spadari, S., Villani, G., and Hubscher, U. (2004) The human DNA polymerase lambda interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF1/CIP1. FASEB J. 18, 1743-1745
27. Mialhe, A., Lafanechere, L., Treilleux, I., Peloux, N., Dumontet, C., Bremond, A., Panh, M. H., Payan, R., Wehland, J., Margolis, R. L., and Job, D. (2001) Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res. 61, 5024-5027
28. Banerjee, A. (2002) Increased levels of tyrosinated α-, and B(III)-, and β(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 293, 598-601
29. Snyder, J. P., Nettles, J. H., Cornett, B., Downing, K. H., and Nogales, E. (2001) The binding conformation of Taxol in β-tubulin: a model based on electron crystallographic density. Proc. Natl. Acad. Sci. U. S. A. 98, 5312-5316
30. Willard, F. S., and Crouch, M. F. (2001) MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit. Cell. Signal. 13, 653-664
31. Pellegrini, F., and Budman, D. R. (2005) Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Investig. 23, 264-273
32. Revenu, C., Athman, R., Robine, S., and Louvard, D. (2004) The co-workers of actin filaments: from cell structures to signals. Nat. Rev. Mol. Cell. Biol. 5, 635-646
33. Yin, H. L., and Stull, J. T. (1999) Proteins that regulate dynamic actin remodeling in response to membrane signaling minireview series. J. Biol. Chem. 274, 32529-32530
34. Papakonstanti, E. A., and Stournaras, C. (2002) Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol. Biol. Cell 13, 2946-2962
35. King, C. C., Gardiner, E. M., Zenke, F. T., Bohl, B. P., Newton, A. C., Hemmings, B. A., and Bokoch, G. M. (2000) p2l-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1). J. Biol. Chem. 275, 41201-41209
36. Thomas, D., Patterson, S. D., and Bradshaw, R. A. (1995) Src homologous and collagen (Shc) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells. J. Biol. Chem. 270, 28924-28931
37. Qian, Y., Corum, L., Meng, Q., Blenis, J., Zheng, J. Z., Shi, X., Flynn, D. C., and Jiang, B. H. (2004) PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am. J. Physiol. 286, C153-C163
38. Rao, J., and Li, N. (2004) Microfilament actin remodeling as a potential target for cancer drug development. Curr. Cancer Drug Targets 4, 345-354
39. Asch, H. L., Head, K., Dong, Y., Natoli, F., Winston, J. S., Connolly, J. L., and Asch, B. B. (1996) Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 56, 4841-4845
40. Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N., Yin, H. L., and Hayoz, D. (2004) Gelsolin superfamily proteins: key regulators of cellular functions. CMLS Cell. Mol. Life Sci. 61, 2614-2623
41. Kayalar, C., Ord, T., Testa, M. P., Zhong, L. T., and Bredesen, D. E. (1996) Cleavage of actin by interleukin 1 β-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. U. S. A. 93, 2234-2238
42. White, S. R., Williams, P., Wojcik, K. R., Sun, S., Hiemstra, P. S., Rabe, K. F., and Dorscheid, D. R. (2001) Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 24, 282-294
43. Morley, S. C., Sun, G. P., and Bierer, B. E. (2003) Inhibition of actin polymerization enhances commitment to and execution of apoptosis induced by withdrawal of trophic support. J. Cell. Biochem. 88, 1066-1076
44. Yamazaki, Y., Tsuruga, M., Zhou, D., Fujita, Y., Shang, X., Dang, Y., Kawasaki, K., and Oka, S. (2000) Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis. Exp. Cell Res. 259, 64-78
45. Honda, K., Yamada, T., Endo, R., Ino, Y., Gotoh, M., Tsuda, H., Yamada, Y., Chiba, H., and Hirohashi, S. (1998) Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 140, 1383-1393
46. Otey, C. A., and Carpen, O. (2004) α-Actinin revisited: a fresh look at an old player. Cell Motil. Cytoskelet. 58, 104-111
47. Zhang, G., He, B., and Weber, G. F. (2003) Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer. Mol. Cell. Biol. 23, 6507-6519
48. Nakanishi, K., Sakamoto, M., Yasuda, J., Takamura, M., Fujita, N., Tsuruo, T., Todo, S., and Hirohashi, S. (2002) Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res. 62, 2971-2975
49. Kim, C. S., Vasko, V. V., Kato, Y., Kruhlak, M., Saji, M., Cheng, S. Y., and Ringel, M. D. (2005) AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology 146, 4456-4463
50. Jiang, K., Sun, J., Cheng, J., Djeu, J. Y., Wei, S., and Sebti, S. (2004) Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol. Cell. Biol. 24, 5565-5576
51. Liang, K., Jin, W., Knuefermann, C., Schmidt, M., Mills, G. B., Ang, K. K., Milas, L., and Fan, Z. (2003) Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. Mol. Cancer Ther. 2, 353-360
52. Obenauer, J. C., Cantley, L. C., and Yaffe, M. B. (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635-3641